CytoMed Therapeutics (GDTC) disclosed a Nasdaq notice for falling below the $1.00 minimum bid price for 30 consecutive business days. It has until April 5, 2027, to regain compliance by hitting $1.00 for ten consecutive sessions. A second 180-day period may be available. Trading is unaffected for now.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
